Novo Nordisk A S
NONOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.
Other share classesNVO
Q1 2024 vs. Q4 2023
How the institutions holding Novo Nordisk A S changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 2 | 3 | +1 |
| Shares | 40.4K | 112.6K | +72.2K (+178.5%) |
| Value | $4.18M | $14.3M | +$10.1M (+242.9%) |
New holders (1)
Institutions that held Novo Nordisk A S at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Atlas Capital Advisors LLC | 5,218 | $660.1K | 0.10% |
Sold out (0)
Institutions that held Novo Nordisk A S at the end of Q4 2023 and filed for Q1 2024 without it.
None.